Latest filing published 03 Mar 2025 for Lexicon Pharmaceuticals, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kristen Alexander: trading record in brief
Kristen Alexander (senior executive) discloses dealings in Lexicon Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 28 February 2022 to 28 February 2025, the count stands at 16 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 March 2025, the filings show an option exercise in Lexicon Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kristen Alexander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,617 sharesCommon StockSEC:0001127602-25-007540:0
- 2,700 sharesCommon StockSEC:0001127602-24-007629:0
- 5,400 sharesCommon StockSEC:0001127602-23-007933:0
- 3,200 sharesCommon StockSEC:0001127602-22-007177:0
4 of 4 declarations